Next Generation Brain Health Depends on Early Alzheimer Disease Diagnosis: From a Timely Diagnosis to Future Population Screening

Journal of the American Medical Directors Association

Volumn 17, Issue 5, 2016, Pages 452-453

  De Roeck, Ellen E ^a   Engelborghs, Sebastiaan ^b   Dierckx, Eva ^c,d  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c Hospital Network Antwerp ZNA Middelheim and Hoge Beuken   (Belgium)

^d Alexian Brothers Hospital   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER;

AGE; ALZHEIMER DISEASE; BEHAVIOR CHANGE; COGNITIVE DEFECT; DEMENTIA; EARLY DIAGNOSIS; HEALTH CARE PERSONNEL; HUMAN; LETTER; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRIMARY HEALTH CARE; RISK FACTOR; SCREENING; BRAIN;

ALZHEIMER DISEASE; BRAIN; EARLY DIAGNOSIS; HUMANS;

EID: 84959899736     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.02.015     Document Type: Letter

References (7)

1. Sperling R.A., Aisen P.S., Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement 2011, 7:280-292.
2. Morley J.E., Morris J.C., Berg-Weger M., et al. Brain health: The importance of recognizing cognitive impairment: An IAGG consensus conference. J Am Med Dir Assoc 2015, 16:731-739.
3. Dubois B., Padovani A., Scheltens P., et al. Timely diagnosis for Alzheimer's disease: A literature review on benefits and challenges. J Alzheimers Dis 2016, 49:617-631.
4. De Lepeleire J., Wind A.W., Iliffe S., et al. The primary care diagnosis of dementia in Europe: An analysis using multidisciplinary, multinational expert groups. Aging Ment Health 2008, 12:568-576.
5. Wimo A., Winblad B. Brain health: A primary health care viewpoint. J Am Med Dir Assoc 2015, 16:720-721.
6. Lleó A., Cavedo E., Parnetti L., et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. Nat Rev Neurol 2015, 11:41-55.
7. Woo J. Brain health: The importance of recognizing cognitive impairment: An Asian viewpoint. J Am Med Dir Assoc 2015, 16:722-723.